Frequently Asked Questions
FAQs
WHAT IS THE AC-130 VIPER?
The AC-130 Viper is a localized CO₂ cooling device under development by New York Cryogen, Inc
WHAT IS ITS CURRENT REGULATORY STATUS?
FDA 510(k) clearance for the AC-130 Viper is pending
IS THE AC-130 VIPER AVAILABLE FOR PURCHASE OR COMMERCIAL USE IN THE UNITED STATES?
No. The AC-130 Viper is not available for commercial distribution in the United States.
WHAT IS THE PRODUCT’S INTENDED USE?
Final intended-use and labeling information will be published only after the applicable regulatory review is complete.
ARE THE SPECIFICATIONS FINAL?
No. The product remains under development, and its configuration and public specifications may change.
CAN I RESERVE A DEVICE OR BOOK A TREATMENT THROUGH THIS WEBSITE?
No. This website does not accept product orders or reservations and does not schedule treatment with the AC-130 Viper.
HOW CAN I RECEIVE UPDATES?
Join the company’s product-development update list or contact New York Cryogen for general business information.
Join the Pain Relief Revolution
The AC-130 VIPER is set for distribution in Spring 2024. Healthcare professionals passionate about cutting edge pain relief solutions are encouraged to connect with us.